UK pharmacists are demanding a change in the culture around provision of Medicines Use Reviews, Chemist + Druggist reports.
C+D polled its readers about MURs following controversy over allegations Boots was pressuring its pharmacists to peform the reviews where they were not necessary and aiming for the 400-a-year cap as a target.
45% of C+D readers told the pharmacy magazine that MURs were no longer “fit for purpose”.
Among the rest, 19% suggested reducing or removing payments for delivering MURs, and another 18% suggested stronger regulation. Another 18% said pharmacists require condition-specific guidelines regarding how to undertake the reviews.
A Twitter debate undertaken by C+D using the hashtag #MURabuse revealed the need for a culture change and new approach to MURs.
@CandDAnnabelle I feel we have started to look at MURs the wrong way. 400 is a limit, not a target. There needs to be a culture change
— Chris Bonsell (@ChrisBCPPE) April 22, 2016